WT1-Mutant Wilms Tumor Progression Is Associated With Diverting Clonal Mutations of CTNNB1

J Pediatr Hematol Oncol. 2021 Mar 1;43(2):e180-e183. doi: 10.1097/MPH.0000000000001697.

Abstract

WT1-mutant Wilms tumors exhibit a high rate of concomitant CTNNB1 mutations, associated with activated Wnt signaling. Here, we show by laser and manual microdissection of different histologic cell types from 6 WT1-mutant tumor samples that 1 patient's tumor can contain up to 4 distinct mutations in CTNNB1 and/or WTX. Consecutive sections may also harbor different CTNNB1 mutations. The variability of activating CTNNB1 mutations demonstrates the multifocal nature of WT1-mutant Wilms tumors. As multiple independent tumors can occur in patients with constitutional WT1 mutations, they need to be surveyed more closely for tumor development.

MeSH terms

  • Clonal Evolution*
  • Disease Progression
  • Humans
  • Kidney Neoplasms / genetics
  • Kidney Neoplasms / pathology*
  • Mutation*
  • Prognosis
  • WT1 Proteins / genetics*
  • Wilms Tumor / genetics
  • Wilms Tumor / pathology*
  • beta Catenin / genetics*

Substances

  • CTNNB1 protein, human
  • WT1 Proteins
  • WT1 protein, human
  • beta Catenin